"
National Pharmaceutical Council experts will participate on several panel discussions during Virtual ISPOR 2020, an online meeting running from May 18-20, 2020.
Be sure to check out the following panel presentations:
Breakout Session 6: Non-randomized Real-World Evidence: Are We Ready for Action?
Tuesday, May 19, 2020
2:30 p.m. - 3:30 p.m. ET
Speakers:
- Pamela Bradt, MD, MPH, Chief Scientific Officer, Institute for Clinical and Economic Review
- Katsiaryna Bykov, PharmD, ScD, Instructor in Medicine, Harvard Medical School and Pharmacoepidemiologist, Department of Medicine, Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
- Jessica Daw, PharmD, MBA, Vice President of Pharmacy, Optima Health
- Jennifer Graff, PharmD, Vice President, Comparative Effectiveness Research, NPC (Moderator)
Breakout Session 8: Is Shared Decision-making Worth It? Evidence of Impact on Cost and Utilization and Unintended Consequences
Tuesday, May 19, 2020
5:30 p.m. - 6:30 p.m. ET
Speakers:
- Alan Balch, PhD, Chief Executive Officer, Patient Advocate Foundation
- Karen Fields, MD, Medical Oncologist, Moffitt Cancer Center
- Theresa Schmidt, MA, Vice President, Discern Health
- Kimberly Westrich, MA, Vice President, Health Services Research, NPC (Moderator)
Breakout Session 11: Patient-centered Multi-criteria Decision Analysis - Methods to Advance Value Beyond the Status Quo
Wednesday, May 20, 2020
3:15 p.m. - 4:15 p.m. ET
Speakers:
- Jennifer Bright, MPA, Executive Director, Innovation and Value Initiative
- Jon Campbell, PhD, Associate Professor, Department of Clinical Pharmacy, Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Services, University of Colorado Anschutz Medical Campus
- Elisabeth Oehrlein, PhD, MS, Senior Director, Research & Programs, National Health Council
- Kimberly Westrich, MA, Vice President, Health Services Research, NPC
Registration is required to view the presentations. For further information, visit ISPOR's website.
Â
"